(Q41731959)

8 October 2017

1 reference

title

Treatment of diabetic dyslipidemia (English)

1 reference

8 October 2017

1 reference

A Garg

1

1 reference

PubMed ID

9526814

8 October 2017

language of work or name

English

0 references

publication date

1 February 1998

1 reference

American Journal of Cardiology

8 October 2017

1 reference

8 October 2017

81

1 reference

8 October 2017

4A

1 reference

8 October 2017

47B-51B

1 reference

Non-insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosis

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900038-1

Evidence for diabetes mellitus and genetic forms of hypertriglyceridemia as independent entities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900038-1

Management of dyslipidemia in NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900038-1

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900038-1

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900038-1

Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900038-1

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900038-1

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900038-1

Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900038-1

Mechanism of action of gemfibrozil on lipoprotein metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900038-1

Gemfibrozil alone and in combination with lovastatin for treatment of hypertriglyceridemia in NIDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900038-1

Effects of Nicotinic Acid Therapy on Plasma High Density Lipoprotein Subfraction Distribution and Composition and on Apolipoprotein A Metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900038-1

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900038-1

Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900038-1

Efficacy and safety of controlled-release niacin in dyslipoproteinemic veterans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900038-1

Postheparin lipolytic activity and plasma lipoprotein response to omega-3 polyunsaturated fatty acids in patients with primary hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900038-1

Suppression by diets rich in fish oil of very low density lipoprotein production in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900038-1

Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900038-1

Elevated plasma glucose and lowered triglyceride levels from omega-3 fatty acid supplementation in type II diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900038-1

10.1016/S0002-9149(98)00038-1

7 January 2021

Identifiers

DOI

1 reference

8 October 2017

1 reference

PubMed ID

9526814